Can Atrial Fibrillation (AFib) lead to Supraventricular Tachycardia (SVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, Atrial Fibrillation (AFib) does not typically lead to Supraventricular Tachycardia (SVT), but rather the relationship between the two conditions can be more complex.

Key Points

  • The guidelines for the management of patients with atrial fibrillation suggest that other types of supraventricular tachycardia may degenerate into AF, but not the other way around 1.
  • SVT can be an initiating event for AF, and eliminating the initiating arrhythmia may abolish AF 1.
  • Specific cardiovascular conditions associated with AF include valvular heart disease, coronary artery disease, and hypertension, as well as sinus node disease, ventricular pre-excitation, and supraventricular tachycardias 1.
  • The relationship between AF and SVT is complex, and while AF may be associated with SVT, it is not typically a direct cause of SVT.
  • Treatment of underlying conditions, such as SVT, may be necessary to manage AF effectively 1. Some key arrhythmias that can cause AF include:
  • AV node reentry
  • AV reentry These arrhythmias can often be cured by radiofrequency catheter ablation, which may also abolish AF 1.

From the Research

Relationship Between Atrial Fibrillation and Supraventricular Tachycardia

  • Atrial Fibrillation (AFib) and Supraventricular Tachycardia (SVT) are both types of arrhythmias, but they have distinct characteristics and triggers.
  • According to 2, SVT may trigger AFib, and ablation of SVT can prevent AFib recurrences in some patients.
  • The study found that 10.1% of patients referred for AFib ablation had inducible SVT, and ablation of SVT was successful in all cases.

Incidence of Atrial Fibrillation in Patients with Supraventricular Tachycardia

  • Research suggests that there is a significant incidence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia (PSVT) 3, 4.
  • A study found that 19% of patients with PSVT developed atrial fibrillation during a mean follow-up period of 31 months 4.
  • Another study reported that 18% of patients with atrioventricular nodal reentry tachycardia (AVNRT) developed atrial fibrillation 3.

Mechanisms and Triggers

  • The mechanism of SVT can be due to altered automaticity, triggered activity, or reentry 5.
  • Atrial fibrillation can occur in patients with AVNRT, and its incidence is higher than expected for the general population 3.
  • The occurrence of atrial fibrillation is not related to the mechanism or heart rate of the paroxysmal supraventricular tachycardia 4.

Diagnosis and Management

  • Supraventricular tachycardia can be diagnosed using electrocardiography, and the underlying mechanism can often be deduced from the ECG during tachycardia 6.
  • Management of SVT includes vagal maneuvers, adenosine, beta-blockers, and calcium channel blockers, and catheter ablation is curative in the majority of patients 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2010

Research

Pathophysiology of supraventricular tachycardia.

European heart journal, 1993

Research

Supraventricular tachycardia: An overview of diagnosis and management.

Clinical medicine (London, England), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.